Biologic and molecular prognostic factors--impact on treatment of patients with non-small cell lung cancer.

doi:10.1378/chest.107.6_supplement.287s

Back to search

Article

Biologic and molecular prognostic factors--impact on treatment of patients with non-small cell lung cancer.

Chest - 1 Jun 1995

Johnson B E

Abstract excerpt

A wide range of genetic and phenotypic abnormalities have been identified in lung cancer. However, only a few are known to have an impact on patient outcome and thus may influence choice of therapy. Biologic and molecular factors known in this regard include the epidermal growth factor family and...

Topics

Biomarkers, Tumor
Carcinoma, Non-Small-Cell Lung
Epidermal Growth Factor
ErbB Receptors
Genes, ras
Growth Substances
Humans
Lung Neoplasms
Mutation
Prognosis
Survival Rate
Transforming Growth Factor alpha

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.